ISHLT2019 offers an exciting line-up of eight symposia that are of great interest to the contemporary heart failure and transplant communities. Future Shock: Great Debates in Cardiogenic Shock will feature three lively debates between leading clinicians on approaches to manage patients with cardiogenic shock, ranging from hemodynamic management to temporary mechanical circulatory support.
Special heart failure populations require unique management approaches, and these will be highlighted in Heart Failure in Adult Congenital Heart Disease: Unique Problems Need Unique Solutions, which will discuss controversial topics such as the timing of transplantation in ACHD patients, strategies for combined heart-liver transplantation, and use of mechanical circulatory support.
The management of patients with restrictive cardiomyopathies will be highlighted in the cutting-edge symposium entitled In the Thick of It: Hypertrophic and Amyloid Cardiomyopathies.
Novel and sophisticated imaging techniques have been developed to better characterize and manage complex heart failure patients, and these will be explored in a joint symposium between the ISHLT and Society of Cardiac Magnetic Resonance: Joint ISHLT/SCMR Symposium: Cardiac MRI and the World of Heart Failure: When Two Disciplines Harmonize. Ultimately, many of these patients will require transplantation, but the donor organ shortage continues to restrict heart transplant activity worldwide. Innovative strategies to increase donor utilization, including use of marginal donors, hepatitis C positive donors, and donors from distant locations will be explored in All Talk, No Action? New Strategies and Best Practices to Maximize Donor Heart Utilization, which will culminate in an animated debate about the pros and cons of Opt Out vs Opt In policies for organ donation.
Clinicians actively involved in the care of heart transplant recipients will benefit from cutting-edge talks on strategies to personalize and minimize immunosuppression in One Size Does Not Fit All: Personalized Medicine in Heart Transplantation, while experts in coronary imaging and pharmacology will discuss the diagnosis, prevention, and treatment of cardiac allograft vasculopathy. This symposium, entitled Cardiac Allograft Vasculopathy: Have Hope, Ye Who Enter, will end with a captivating debate on the role of revascularization and defibrillators for CAV treatment.
Provocative approaches to replace heart transplantation will be presented by outstanding international leaders in the fields of cardiac 3D printing, xenotransplantation, and stem cell therapy in Print, Replace, or Innovate: Alternative Strategies to Cardiac Transplantation. Finally, numerous abstract presentations throughout the meeting will present the results of innovative, on-going research in the fields of advanced heart failure and transplantation.